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Abstract 
Background: Aristaless-related homeobox (ARX) is a paired-like homeodomain transcription factor that functions pri-
marily as a transcriptional repressor and has been implicated in neocortical interneuron specification and migration. 
Given the role interneurons appear to play in numerous human conditions including those associated with ARX muta-
tions, it is essential to understand the consequences of mutations in this gene on neocortical interneurons. Previous 
studies have examined the effect of germline loss of Arx, or targeted mutations in Arx, on interneuron development. 
We now present the effect of conditional loss of Arx on interneuron development.
Results: To further elucidate the role of Arx in forebrain development we performed a series of anatomical and devel-
opmental studies to determine the effect of conditional loss of Arx specifically from developing interneurons in the 
neocortex and hippocampus. Analysis and cell counts were performed from mouse brains using immunohistochemi-
cal and in situ hybridization assays at 4 times points across development. Our data indicate that early in develop-
ment, instead of a loss of ventral precursors, there is a shift of these precursors to more ventral locations, a deficit that 
persists in the adult nervous system. The result of this developmental shift is a reduced number of interneurons (all 
subtypes) at early postnatal and later time periods. In addition, we find that X inactivation is stochastic, and occurs at 
the level of the neural progenitors.
Conclusion: These data provide further support that the role of Arx in interneuron development is to direct appro-
priate migration of ventral neuronal precursors into the dorsal cortex and that the loss of Arx results in a failure of 
interneurons to reach the cortex and thus a deficiency in interneurons.
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Background
Aristaless-related homeobox (ARX) is a paired-like 
homeodomain transcription factor that functions pri-
marily as a transcriptional repressor and has been 
hypothesized to be important for interneuron specifica-
tion and migration [1–6]. Patients harboring a mutation 
in ARX present with a spectrum of neurological disorders 
ranging in severity from lissencephaly with ambigu-
ous genitalia (XLAG syndrome) to those with isolated 
intellectual disabilities (ID) [7–9]. All patients with ARX 
mutations have some degree of intellectual disability, 
and almost all develop epilepsy during early childhood. 
A relatively consistent genotype-phenotype correlation 
exists with ARX mutations: protein truncation or homeo-
domain loss of function results in both ID and epilepsy 
with severe structural defects, while point mutations 
outside the homeodomain or expansions in one of the 4 
alanine tracts leads to ID and epilepsy phenotypes alone 
[5, 7]. Mice with mutations in Arx, such as an alanine 
tract expansion or specific point mutations, reproduc-
ibly model many of these phenotypes including a strik-
ing developmental epilepsy [10, 11]. Additional studies 
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suggest the epilepsy phenotype is largely or entirely the 
result of a cortical interneuron defect [2, 12].
This “interneuronopathy hypothesis” proposes that a 
developmental deficiency of inhibitory cortical interneu-
rons caused by defects in proliferation, specification, dif-
ferentiation and/or migration, results in epilepsy [13, 14]. 
Our previous findings are consistent with this hypothesis; 
the epilepsy phenotype was observed in mice in which 
Arx was conditionally abrogated from interneurons (the 
Arx−/Y; Dlx5/6cre-IRES-GFP(CIG) cross) but not when Arx is 
selectively excised from dorsal progenitors of projection 
neurons (Arx−/Y; EmxCRE cross) [2, 12]. These mouse 
models supports the interneuronopathy hypothesis, how-
ever none of our previous studies investigated the full 
alteration in interneurons in the Arx mice.
Although previous studies (including from our labs) on 
both Arx−/y and Arx−/Y; Dlx5/6(CIG) mice have a cortical 
interneuron deficit, many interneurons still persist in the 
neocortex [2, 8, 11]. Our previous studies have evaluated 
adult cortical and hippocampal interneurons, but did not 
completely characterize the various interneuron subtypes 
and how interneurons change through development [2]. 
Hence, identifying the subpopulations of interneurons 
that persist and how they function remains an important 
question that may help in understanding not only the 
pathobiology underlying ARX mutations, but also poten-
tially other forms of developmental epilepsies with intel-
lectual disabilities.
Interneurons can be subdivided by morphology, neu-
rochemistry and electrophysiologic properties [15–17]. 
While a number of transcription factors have been iden-
tified as critical to establishing the diversity of interneu-
ron subtypes, the specific role of these transcription 
factors in delineating interneuron subpopulations is 
incompletely understood. The Dlx transcription factors, 
expressed early in the interneuron lineage, appear to be 
essential in controlling interneuron fate [18, 19]. Mul-
tiple other transcription factors (for example Nkx2.1, 
Lhx6, and Sox6) have also been identified as necessary 
for interneuron subtype determination, refinement of the 
lateral, medial, and caudal ganglionic eminence popula-
tions, and migration to the olfactory bulb, striatum, and 
cortex (For review see [15, 20, 21]). Though it is clear that 
loss of Arx alters interneuron development, and that Arx 
function is primarily, though not exclusively, downstream 
of the Dlx transcription factors, the ultimate role of Arx 
in this process is incompletely understood [22].
To further define the interneuron populations 
impacted by loss of Arx we analyzed interneuron sub-
types through development in mice conditionally mutant 
for Arx in interneurons. Our data, which expands our 
previous studies [2], indicate that early in development, 
instead of a loss of ventral precursors, there is a shift of 
these precursors to more ventral locations, a deficit that 
persists in the adult nervous system. The result of this 
developmental shift is a reduced number of all subtypes 
of interneurons at early postnatal and later time periods. 
These data suggest that ARX is important for the dorsally 
directed migration of most interneurons into the cortex 




All experiments were approved by the Children’s Hos-
pital of Philadelphia Animal Care and Use Commit-
tee. The animals were kept in standard mouse cages, on 
a 12-h light/dark cycle, and allowed free access to food 
and water. The care and husbandry of the mouse col-
ony followed previous descriptions [1, 2]. For this study 
double or single floxed females (Arxfl/fl and Arxfl/+) 
were crossed to Dlx5/6CIG(cre-IRES-GFP) males [23]. In 
addition, the Dlx5/6CIG males were mated with tdTo-
mato reporter mice (tdTomatofl-stp/fl-stp) (from Jackson 
Labs- Ai9(RCL-tdT)- stock number 007909) to generate 
DlxCIG;tdTomato+/− males. These males were crossed to 
Arxfl/fl females to generate animals that had tdTomato 
expression in Dlx5/6 progenitors either with or without 
Arx. Arxfl/+ or Y, Dlx5/6CIG, and the CD1 and C57/Bl6 
background genotypes were all considered controls.
Gross anatomy and histology
P14 and adult Animals were deeply anesthetized and 
then transcardially perfused with PBS followed by 4  % 
paraformaldehyde. The brains were harvested, weighed, 
further fixed in 4 % paraformaldehyde overnight at 4 °C, 
and then transferred to PBS. Each whole brain was care-
fully viewed to characterize gross morphologic differ-
ences. Four tissue blocks were prepared: (1) posterior 
boundary of the olfactory bulbs to 2  mm posterior on 
the frontal cortex, (2) frontal cortex to 2 mm anterior to 
the optic chiasm, (3) 2  mm anterior to 1  mm posterior 
to the chiasm, and (4) 1 mm posterior to the chiasm to 
the occipital cortex. The four tissue blocks were embed-
ded in paraffin and sections cut at 4 µm for histology and 
immunohistochemical studies. One slide per region was 
stained with hematoxylin and eosin.
Immunohistochemistry
Immunohistochemistry was performed using a stand-
ard protocol as previously performed in our lab with 
antibodies against interneuron markers (Calb-calbindin, 
Calr-calretinin, Parv—parvalbumin, NPY—Neuropep-
tide Y, and SST—somatostatin), GFP (anti-GFP) and Arx 
(see Table  1 for manufacture information and staining 
parameters) [2, 3, 12]. Antigen retrieval was performed 
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by microwaving (2 min on high, 3 min at medium power) 
the slides in citric acid buffer. Secondary antibodies are 
presented in Table 1.
In situ hybridization
e14 and >P30 mice were processed as described 
above and in  situ hybridization performed as previ-
ously described [12]. Briefly, all slides were baked at 
65  °C, post-fixed in 4 % PFA, washed in PBS with 0.1 % 
Tween-20 (PBT) and acetylated for 10 min in 0.1 M TEA 
(1.86 % triethanolamine, 0.4 % 10 N NaOH, 0.5 % acetic 
anhydride, and water). The glutamate decarboxylase 67 
(GAD67) probe (courtesy of Dr N. Tillakaratne; Erlander 
et  al. [24]) was added at 1:1000 in hybridization solu-
tion and incubated overnight at 65  °C. Slides were then 
washed and incubated in MABT pH 7.5 (100 mM maleic 
acid, 150 mM NaCl, 0.1 % Tween-20, and water), block-
ing agent, and 20 % goat serum for 1 h at room temper-
ature. Next, the slides were incubated overnight at 4  °C 
in MABT with 2 % blocking reagent and 5 % goat serum 
and anti-DIG antibody 1:2500 (Roche, 11093274910). 
The reacted slides were then washed and incubated with 
1  mL of BM Purple (Roche, 11442074001) in the dark, 
overnight at room temperature. Lastly, the slides were 
washed with NTM and PBS, fixed in PFA, dehydrated to 
100 % ethanol, stepped to Xylene and mounted with Per-
mount (SP15-500, Fisher Scientific).
Imaging and cell counting
The tissue was visualized using a Leica DMR micro-
scope (Leica Microsystems, Bannockburn, IL) equipped 
with epifluorescence and light microscopy. The images 
were acquired with an Orca digital camera (Hamamatsu, 
Hamamatsu City, Japan) and processed in Image Pro® 
software for cell counting. Sections from the most ante-
rior block (in M1 and lateral neocortex), sections from 
the optic chiasm block (S1 and lateral neocortex), and 
sections through the hippocampus (in sagittal section) 
were chosen for cell counting. Two 10× magnification 
images were taken and stitched together to produce a 
continuous image from the ventricular to pial surface. 
Fully labeled cells were measured and numbered from 
a reference point on the ventricular surface in the mid-
dle of the acquired image. This method insures accurate 
measures of the distance from the ventricular surface 
(layer and location information) as well as numbers of 
cells (total quantitative information). All counting was 
performed blind with respect to the genotype by two 
individuals. Counts from sections were averaged for each 
animal and then compared between genotypes.
Statistical analysis
All statistics were performed in Matlab using the statis-
tics toolbox. A first test of differences between groups 
was performed using an N-way ANOVA. Each geno-
type was considered as an independent variable. For 
all ANOVA calculations, the main effect had 4 degrees 
of freedom based on 5 genotypes: (1) wild type (Bl6/
C57), (2) Arxfl/+ or y (3) Dlx5/6CIG (4) Arx−/+;Dlx5/6CIG 
(female Hets); and (5) Arx−/y;Dlx5/6CIG (ARX-/Y). The 
level of significance was set at α  =  0.01. As there was 
no difference between the control genotypes in the cell 
count analysis (data not shown), the N-way ANOVA was 
repeated with the Arxfl/+ or y, Dlx5/6CIG and wildtypes 
pooled as the control group and compared to the Arx−/+; 
Dlx5/6CIG (female Hets); and Arx−/y; Dlx5/6CIG (ARX-/Y 
Table 1 Primary and secondary antibodies
Primary antibody Species Company Dilution
Calretnin Rabbit Swant 1:100
Arx Rabbit Gift from Kunio Kitamura 1:1000
Calbindin Rabbit Swant 1:500
SST (somatostatin) Rabbit ABCAM (Epitomics) 1:50
Nkx2.1
 GFP Rabbit Cell Signaling 1:800
 NPY Rabbit Millipore 1:500
 Parvalbumin Mouse Millipore 1:100
Secondary antibody AB Species Company Dilution
Biotin Anti rabbit Donkey Jackson Immuno 1:500
Biotin (H+L) & (Fab’) Anti goat Donkey Jackson Immuno 1:500
Biotin Anti mouse Goat Jackson Immuno 1:500
FITC Anti rabbit Goat Jackson Immuno 1:50
TRITC Anti rabbit Donkey Jackson Immuno 1:50
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males). After calculation of the ANOVA, post hoc analy-
sis of sub group differences was performed in Matlab 
using the ‘anovarep’ function that performs a Holm-Sidak 
test for multiple comparisons to determine if subgroups 
are different (http://www.mathworks.com/matlabcen-
tral/fileexchange/18746). In addition, the combined con-
trol group was independently compared to the Arx−/+; 
Dlx5/6CIG (female heterozygous mice) in the adult ani-
mals with Student t-tests.
For the embryonic time points, due to the many densely 
packed cells, which posed significant difficulties counting 
individual cells, we used a ranking method to quantify 
the differences between the genotypes. For this method, 
we printed out and presented the photo-micrographs of 
each of the regions of interest (ROI) to 6 individuals who 
were blinded to the genotype. Raters were asked to rank 
the photo-micrographs in order of number of labeled 
cells in the region of interest with the image showing the 
greatest number of labeled cells ranked 1, and the image 
showing the fewest labeled cells ranked last. The rankings 
were averaged across all individuals. Then the mutant 
and wild type group ROI averages were compared using a 
three way ANOVA (see above for details).
For quantification of embryos and pups born at dif-
ferent ages, we performed a Chi-square test with the 
expected ratio being normal Mendelian ratios. This was 
compared to the actual ratios of fetuses harvested or 
pups born and survived to P14.
Results
Previous studies querying Arx function have shown an 
important role in interneuron development and sug-
gested a role in both migration and cell differentiation [8, 
22, 25, 26]. These studies employed a complete knockout 
of Arx to assess the ventral forebrain role of Arx, possibly 
complicating the analysis as dorsal progenitor function 
is also altered. Hence, to analyze the cell autonomous 
role of Arx in interneuron development we generated 
Arx conditional mutant mice with near complete loss 
of Arx from the ventral forebrain at e14.5 (embryonic 
day 14.5) in Arx−/Y; Dlx5/6CIG males (Fig. 1A–A″, insets 
a″). In females there were radially oriented streams of 
Arx within and emerging from the GE ventricular zone, 
which varied dramatically between embryos (Fig.  1A′, 
insets). This apparent loss of some Arx cells dissipated 
when the Arx cells migrated into the subventricular and 
mantle zones of the GE and mixed with the Arx posi-
tive cells (Fig. 1A′, asterisk, insets). Loss of Arx was more 
variable in males than females (Fig. 1A′, A″, insets). The 
striated expression in Arx−/+; Dlx5/6CIG female animals 
(Fig.  1A′, boxed areas) occurred on some level in all 
females and appears to be clonal proliferations of Arx 
positive or negative cells that migrate radially away from 
the VZ of the GE. The striation occurs in the VZ of the 
GE suggesting this is the site of random X-inactivation in 
the ventral forebrain.
While Arx was clearly lost from the GE precursors, the 
regional anatomy of the GE at e14.5 was unchanged, sug-
gesting that there was no loss of cells, but only a loss of 
Arx (for example compare ventral forebrain in Fig.  1A, 
or Fig.  2). To confirm this observation we performed 
in situ hybridization for Gad67 on wildtype and mutant 
embryos. We observed that the overall number and loca-
tion of the Gad67 positive cells was unchanged (Fig. 2B, 
B′). To further verify that Dlx progenitor cells are not 
lost with abrogation of Arx in the Arx−/y males, we fate 
mapped Dlx5/6 positive cells by crossing Dlx5/6CIG 
mice to tdTomato reporter mice and then crossed the 
F1 generation to Arxfl/fl animals. At e14.5, there was no 
change in the ventral expression of fate mapped Dlx5/6 
progenitors (Fig.  2C, C′). Finally, a secondary check on 
the regional expression pattern was performed by deter-
mining if expression of Nxk2.1 was altered in the Arx−/y 
males by performing immunohistochemistry on the 
e14.5 sections from the Arxfl/lf to Dlx5/6CIG cross. As 
expected with no change in Gad67 expression, there was 
no change in the expression of the Nkx2.1 as well. Stain-
ing for the intrinsic GFP in these animals also showed no 
change in Dlx5/6 expression, confirming the tdTomato 
data (Fig. 2C, C′). These data support the previous work 
of Collombat and colleagues which suggests Arx is not 
important for interneuron progenitor maintenance or 
fate specification as all cells remain and differentiate into 
Gad positive neurons [8, 26].
Prior reports by Kitamura and Collombat had demon-
strated that the interneurons that did migrate to the cor-
tex were found primarily in the SVZ and not in the IZ 
and MZ [8, 25]. In these studies, Arx was also removed 
from the dorsal VZ raising the possibility that interneu-
ron development was indirectly influenced by the dorsal 
loss of Arx. Our data support and expand these previ-
ous reports; we find that in Arx−/y; Dlx5/6CIG mice, very 
few cells migrate out of the GE and then primarily into 
the SVZ migratory stream of the dorsal cortex leading to 
very few cells present in the developing cortex (Figs. 1A, 
2). The migrating cells appear to enter the cortex appro-
priately as we found no statistically significant shift to 
lower layers at P14 in surviving Arx−/Y; Dlx5/6CIG mice 
(Fig. 1E, top graph). The ultimate fates of these cells, while 
lower in number also appeared to be unchanged as we 
saw a normal ratio of interneuron subtypes when com-
paring the counts of cells in different sections (e.g. Calb 
WT-38.2 % of Arx positive cells present vs 24.8 in Arx−/y; 
Calr WT-4.3 % vs. Arx−/y-1.8 %; Npy WT-22.8 vs 19.9 %).
Similar to our previous findings, we observed a 
decreased number of Arx−/y; Dlx5/6CIG progeny including 
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numerous perinatal and juvenile deaths [1, 2]. To quan-
tify the prenatal and postnatal loss of mutants, we geno-
typed 12 litters at e14.5. Genotyping performed at e14.5 
gave Mendelian ratios of offspring (27:24:49 %, n = 12 lit-
ters, for animals of genotypes Arx−/Y; Dlx5/6CIG:Arx−/X; 
Dlx5/6CIG:ArxFl/X or ArxFl/Y). The number of Arx−/Y; 
Dlx5/6CIG animals that were present at e18.5 was similar 
to e14.5. However, when litters were allowed to proceed 
to birth and genotyping was performed postnatally, we 
saw a reduction in survival at P12-14 (only 6 Arx−/Y; 
Dlx5/6CIG males out of 15 litters) and at the time of 
weaning; only three Arx−/Y; Dlx5/6CIG mice remained 
in 15 litters (0.02  % of offspring, p  <  0.001 Chi-squared 
test). While the definitive cause of these postnatal deaths 
Fig. 1 Arx expression across the ages in control and Arx−/x and Arx−/y;Dlx5/6CIG mice. A–A″ e14.5 embryos in coronal plane. A control, A′ female het, 
A″ male CKO. Immunohistochemistry for Arx reveals near complete loss of Arx in the ventral pallium, in both VZ, SVZ and developing basal ganglia 
(A″), but persistence in the cortical VZ. There is near complete loss of Arx positive cells in the developing cortex as well in the male CKO (A″). Even 
with loss of Arx, the anatomy of the ventral pallium is unchanged (boxed areas in A″). A′ insets (from area around asterisk in main image) reveals a 
spectrum of X inactivation patterns and variability of expression of Arx in 4 representative examples of heterozygous females at e14.5. Only the GE 
is highlighted in each inset. Stripes of clonal expansion of both Arx absence and presence are observed emanating from the VZ. A″ insets—four 
representative examples demonstrating the variability of loss of Arx in CKO males; from moderate loss (top inset) to complete loss (bottom inset). 
Arrows in A highlight migrating interneurons. B–B″ Representative e18.5 coronal images. B Control, B′ female het, B″ male CKO. At 18.5 there are 
many fewer cell in the Arx−/y;Dlx5/6CIG than in the wildtype, including the dorsal cortex (white brackets), ventral BG (asterisk) and VZ of GE (capped 
black line). There are an intermediate number of cells in both locations in the female heterozygous animals (B′). Again note anatomy of developing 
BG is unchanged in all three genotypes. C–C″ Representative P14 coronal images. C Control, C′ female het, C″ male CKO. Arx staining illustrates that 
the persistent Arx positive cells in the surviving Arx−/y;Dlx5/6CIG mice (C″). In this animal the cells were mostly in the lower layers but there was vari-
ability in the 4 mutants so this was not statistically significant. A similar pattern was also found in many of the heterozygous females (C′) whereas 
the wildtype brains have cells dispersed throughout the cortex (C). D Representative adult coronal images. Upper panel control, lower panel female 
het. No significant differences are noted. E Quantification of Arx cell numbers in cortex and hippocampus at P14 and in adult animals across all 
layers and hippocampal regions. Upper panels are counts from P14 animals. Total is the sum of the counts of all layers. L1–L5 are five equally spaced 
regions that correspond roughly to cortical layers (see “Methods”). Asterisk signifies statistical differences. Lower panels are counts from adult animals. 
LV lateral ventricle, SVZ subventricular zone, VZ ventricular zone, BG basal ganglia, GE ganglionic eminence, Cx developing cortex. Hip hippocampus. 
L1 cortical layer 1, L2/3 cortical layers 2 and 3, L6 cortical layer 6
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remains uncertain, we believe neurological dysfunction is 
likely given both the inability to smell/feed and seizures 
[2, 12]. We do know that the perinatal death is not from 
the pancreatic defect as loss of Arx in the pancreas dur-
ing development does not result in perinatal death [28] as 
previously postulated [29].
To further determine the role of Arx in later interneu-
ron development and interneuron subtype specification, 
we traced the surviving Arx positive cells in males and 
heterozygous females, throughout development. Stain-
ing for Arx in cortical and hippocampal sections from 
Arx−/Y, Arx−/X, and wildtype littermates demonstrated 
that a number of Arx positive cells remained after birth 
(Fig. 1C, D). At e18.5, P14, and in adult mice there was 
significant variability in the number of Arx positive cells 
similar to e14.5 mice. Arx expression at e18.5 was simi-
lar to that seen in e14.5 Arx−/Y animals, with both dem-
onstrating almost complete loss of Arx in the SVZ and 
developing basal ganglia and rare scattered cells in the 
cortex (Fig.  1A″–B″). e18.5 Arx+/− brains also showed 
considerable variability, with some brains having normal 
Arx expression in the cortex and remnants of SVZ in the 
GE and some with a clear reduction (Fig. 1B″ for example 
of almost complete loss of Arx). At P14, in the few sur-
viving Arx−/Y animals, there was a clear reduction in the 
total number of Arx positive neurons, more prominent 
in upper cortical layers with some preservation in deeper 
layers (Fig. 1C″, e for graph of counts; p < 0.004 for whole 
cortex). While a statistical difference was found in all lay-
ers, the lower layers did not have greater differences then 
the upper layers, though in some animals there appeared 
to be more cells in the lower layers (Fig. 1C′, C″). The P14 
Arx+/− mice showed moderate variability with regard to 
cortical interneuron numbers. Some animals had a nor-
mal number and distribution of interneurons while oth-
ers showed a reduction in the number of interneurons 
(Fig. 1C″, E). Hippocampal images were also significantly 
different, although less dramatic then in the cortex of 
Arx−/Y mice at P14 (Fig.  1E, second graph, p  =  0.037, 
images not shown).
Fig. 2 Interneuron migration is altered, but progenitor domains are not at e14.5. For all panels—upper row is control sections, lower row is male CKO. 
A Re-presenting A from Fig. 1 for reference and highlighting anatomy of ventral foerbrain. B In situ hybridization for Gad67 demonstrates normal 
appearance of cells in the ventral pallium (asterisk) and substantial decrease in migrating cells (arrows) in the cortex with remaining cells migrating 
in the SVZ (arrows). C–C′ Further confirmation of preservation of ventral interneuron progenitor pool with Dlx5/6—tdTomato fluorescence being 
unchanged between wildtype and mutant embryos. Anatomy of section is highlighted by dashed white outline. D–D′ Co-labelling of Dlx5/6-GFP 
in green, Nxk2.1 in red and nuclei in blue (DAPI labeling) shows normal Nxk2.1 expression and normal Dlx5/6 expression, again with reduction of 
neurons migrating to cortex. Again note with DAPI labeling that anatomy of ventral forebrain is unchanged in the male CKO. LV lateral ventricle, SVZ 
subventricular zone, VZ ventricular zone, BG basal ganglia, GE ganglionic eminence, Cx developing cortex
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We interpreted the two adult Arx−/y animals where Arx 
labeling appeared normal (data not shown) to be either 
incomplete excision of Arx or mosaicism, with loss of 
Arx in the tail but preservation in the brain. Because of 
this possible mosaicism and few surviving animals, we 
did not count the adult Arx−/y male animals. In adult het-
erozygous females, there again was variability with some 
animals having normal expression and others reduced 
(Fig.  1D, E with the averages being similar; p  =  0.12) 
although differences were noted in the hippocampus 
(p = 0.013, Fig. 1E).
Given the variable expression of Arx in the mature 
WT, Arx+/−, and Arx−/y mouse brains, we next sought 
to define interneuron marker expression through devel-
opment. Immunohistochemistry was performed for 
Calbindin, Calretinin, Somatostatin, NPY, and PV. The 
pattern of calbindin (calb) staining at e14.5 was clearly 
different among the WT, Arx+/−, and Arx−/y mice. Com-
pared to the WT, there was significantly more expres-
sion in the SVZ of the GE (Fig. 3A–A″, asterisk) as well 
as in the ventral telencephalon in the region of the ven-
tral palladium and amygdaloid complex (Fig. 3A–A″, bar 
with ends). The increase ventrally is associated with a 
reduction of Calb positive cells in the dorsal telenceph-
alon (Fig. 3A–A″, arrows). Observer ranking of the pat-
terns of positive cells was significantly different in both 
the GE and cortex using both a whole caudal and rostral 
4x images (Fig. 3C, p = 0.014 and 0.03, n = 6) and with 
focusing in on the ventral forebrain with 20× images 
of both rostral and caudal ventral regions (p 0.024 and 
0.037, n = 6). The rankings indicate more positive stain-
ing in the Arx−/y animals ventrally. The observer ranking 
of the number of positive cells dorsally in both the rostral 
and caudal regions was not significantly different (0.36 
and 0.94, n =  6). At e18.5, no significant differences in 
Calb expression were noted (Fig. 3B–B″, c lower graph); 
however there was a trend in the rostral ventral sections 
showing more staining in the Arx−/y animals (Fig.  3B, 
asterisk, square brackets, p  =  0.07) but no clear differ-
ence in the dorsal cortex in this analysis. By P14, there 
is a significant loss of Calb cells in the hippocampus 
(Fig. 4, oval regions highlighting differences, p = 0.026). 
In the cortex, the number of Calb positive neurons was 
not significantly different among genotypes, however, 
there was considerable variability between sections 
(p =  0.37, WT—83.22 ±  10.7 vs Arx−/y—43.9 ±  19.01). 
Fig. 3 Calbindin immunohistochemistry at 2 embryonic time points reveals a shift in location of Calbindin positive cells. A–A″ Upper row, presents 
coronal sections at e14.5. In the control, Calb positive cells are present primarily ventrally in the POA and the developing amygdala complex (bar 
with ends) and sparsely in the cortex. In the mutants (A′–A″) there is an increase in expression in the SVZ of the GE (asterisk) and throughout the 
developing BG. A few cells still migrate into the cortex, though primarily in the IZ. B–B″ Lower row, presents coronal sections at e18.5. In the control, 
Calb positive cells are present primarily ventrally in the developing amygdala complex (bar with ends) and cortex (brackets), and sparsely in the BG 
(asterisk). In the mutants (B′–B″) there is an increase in expression in the BG (asterisk) and a significant loss in the cortex (brackets), and no changes 
in the developing amygdala (bar with ends). C Displays the quantification of Calbindin positive cell numbers from embryonic ages. All counts are 
presented as average ranking from rostral and caudal (and dorsal and ventral) sections at e14.5 (upper) and e18.5 (lower). LV lateral ventricle, VZ 
ventricular zone, BG basal ganglia, Cx developing cortex, IZ intermediate zone, Hip hippocampus. L1 cortical layer 1, L2/3 cortical layers 2 and 3, L6 
cortical layer 6
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We did note a prominent decrease of calb positive neu-
rons in all regions counted in the Arx−/Y brains. While 
it appeared there were fewer calb positive cells in the 
lower layers (brackets in Fig.  4A–A′), this again did 
not reach statistical significance. In adult Arx−/+ mice, 
despite considerable variability in the number of calb 
positive neurons, with some animals having a decrease 
and others no change, overall the mean was significantly 
different (Fig. 4C–C′, d; p = 0.013 in cortex and 0.01 in 
hippocampus).
Calretinin staining demonstrated a distinct pattern 
with no differences among wildtype and mutant animals 
found at embryonic ages by the ranking analysis (Fig. 5A–
A″, B–B″, p =  0.36, 0.76 for rostral and caudal sections 
respectively) but with a region of staining in the ventral 
caudate and putamen in the ARX−/Y and heterozygous 
females (Fig.  5A–A″, bar with ends) that was not well 
labeled in the wildtype. A trend towards loss of calretinin 
positive cells migrating in the developing cortical plate 
was observed across sections (Fig. 5A–A″ arrows), how-
ever this was not significant by the ranking method. At 
e18.5 and P14 there were no clear differences in Arx−/y 
mice compared to controls (Fig.  5B–B″, C, D–D″, F; 
p  =  0.2, 0.79 rostral and caudal sections, respectively). 
There also appeared to be an increase in calretinin posi-
tive cells in the dentate gyrus (DG) of the hippocampus 
(Fig. 5B–B″, square bracket), but this also did not reach 
significance with our ranking method (Fig.  5C, lower 
graph, p = 0.20). At P14, there was a trend towards signif-
icantly fewer cells in the hippocampus (p = 0.07), but no 
Fig. 4 Calbindin immunohistochemistry at 2 postnatal time points revels a reduction of Calbindin positive cells. A–A″, B–B″ P14 left and middle 
column sections illustrates that Calb positive cells are present throughout the cortex and hippocampus, but with a reduction in the number of 
labeled cells. There was a trend toward more cells in the lower layers (curved brackets) but this did not reach significance. The hippocampus at P14, 
shows more significant changes (B–B″; dashed circles in CA1 and CA3 stratum radiatum). In the adult animal, (right column; C, C′) there is also a clear 
reduction in the number of Calb positive cells in the Arx+/− female (C′) versus control (C). D Displays the quantification of Calbindin positive cell 
numbers from post-natal ages. All adult section counts are presented as a percent change from control in both the cortex and hippocampus. LV 
lateral ventricle, VZ ventricular zone, DG dentate gyrus, CA1 Cornus Ammonis 1, CA3 Cornus Ammonis 3. Pia pia matter, L1 cortical layer 1, L2/3 corti-
cal layers 2 and 3, L6 cortical layer 6
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change in the cortex. There was a decrease in calretinin 
staining in the cortex of adult Arx+/− mice (Fig. 5E–E′, F, 
p = 0.05) but not in the hippocampus (p = 0.87, Fig. 7F, 
lower graph).
In addition to using Arx, Calb and Calr as markers that 
we could track from prenatal to postnatal time points, 
we looked for changes in interneurons in older animals 
with immunohistochemistry for neural peptide Y (Npy), 
parvalbumin (Parv) and somatostatin (SOM). Immuno-
histochemical expression of Npy was absent at e14.5 in 
wildtype animals, corresponding to the in situ hybridiza-
tion data from the Allen brain atlas (brain-map.org). At 
e18.5 there was a significant decrease in numbers of Npy 
positive cells in the ventral forebrain of the Arx−/Y ani-
mals, with no difference dorsally (p  =  0.02 and 0.07 in 
ventral rostral and caudal regions respectively and 0.83 
and 0.15 in dorsal rostral and caudal regions). By P14, the 
loss of Npy cells in the cortex of the mutant animals per-
sisted (Fig. 6A–A″, E; p = 0.039) but not in the hippocam-
pus (Fig. 6B–B″, E; p = 0.32). In the heterozygous female 
adult animals there was no overall difference in either cor-
tex or hippocampus, though a trend towards a decrease in 
the cortex was noted (Fig. 6C–C′, D–D′, E; p = 0.19).
For Somatostatin staining there was no expression in 
the embryonic ages by immunohistochemistry or in situ 
(from Allen Brain Atlas; brain-map.org) and in P14 and 
adult (female heterozygous only) there were no differ-
ences noted between the mutant and wildtype mouse 
brains (data not shown).
Lastly, the expression of Parv was compared between 
the wildtype and mutant animals. Parv is not expressed 
until P14 in the mouse (Brain-map.org). At P14 there 
was an interesting and paradoxical finding: a decrease in 
the Parv labeled neurons in the hippocampus of mutant 
males (Fig.  7B–B″, E; p =  0.019) but an increase in the 
cortex (Fig.  7A–A″, E; p  =  0.0007, fourfold increase). 
In the heterozygous females there was a trend toward a 
decrease in the cortex and no change in the hippocampus 
(Fig. 7C–C′, D–D′, F; p = 0.17 and 0.46, respectively). As 
with Arx immunohistochemistry, Parv labeling showed 
considerable variability in females.
Overall, these results demonstrate that loss of Arx in the 
ventral pallium in the developing ganglionic eminences 
result in a shift of GE cells ventrally and a loss of the cells 
migrating into the dorsal forebrain. These changes ulti-
mately lead to an early death in the males and a variable 
phenotype in the females as previously reported [2].
Discussion
Conditional loss of Arx from the Dlx5/6 expressing popu-
lation of neural progenitors results in an early postnatal 
death in males and results in survival but variable expres-
sion of Arx in females. From these observations we pos-
ited that mice with efficient deletion of Arx were dying 
due to a defect in inhibitory transmission and result-
ant neurological deficits. Our results indicate that cells 
in which Arx is lost still express the inhibitory marker 
Gad67 but fail to normally migrate to the cortex. We 
observed a shift in the cells that expressed Arx to more 
ventral fates with expansion of the Calbindin and possi-
bly Calretinin positive interneuron populations in these 
mice. At later time points, the expected loss of Calb, Npy, 
Sst, and Parv interneuron markers was observed. As we 
will discuss below, our data confirms the role of Arx in 
interneuron development and strengthens the evidence 
that Arx is not needed for expression of interneuron 
markers, rather Arx appears to be important for the nor-
mal migration of neurons from the GE into the cortex.
The effect of Arx loss on interneuron populations 
and survival
The early lethality of mice with the interneuron-specific 
deletion of Arx underscores the importance of this gene. 
The phenotype of Arx−/Y; Dlx5/6CIG mutant animals 
is in fact, more severe than we previously reported [2]. 
We had assessed the EEG background, presence of sei-
zures, and interneuron populations in the adult male 
and female mice that we believed were due to a complete 
(See figure on previous page.) 
Fig. 5 Calretinin immunohistochemistry at 2 embryonic and 2 post natal time points reveals alteration of expression across the ages. The top row 
(E14.5, A–A″) demonstrates effect of loss of Arx on Calr staining from representative e14.5 coronal images. There is an increase in the number of 
cells in the region of the developing internal capsule in the Arx−/y;Dlx5/6CIG compared to the wildtype (bar with ends) and the Arx+/− female has an 
intermediate number of labeled cells. In contrast, there is a decrease in the number of scattered cells throughout the ventral pallium. Dorsally, all 
three genotypes have a similar appearing clear migratory stream through the MZ/CP region (arrows). E18.5 (second row, B–B″) illustrates no major 
differences in Calr cells either ventrally or dorsally, with accumulating cells found in the hippocampus in all three genotypes (bracket). C Presents the 
quantification of the two embryonic time points. All counts are presented as average ranking from rostral and caudal (and dorsal and ventral) sec-
tions at e14.5 (upper) and e18.5 (lower). Adult Ages; P14 (third row; D–D″) sections illustrate that Calr positive cells are present throughout the cortex 
in control mice. There is a trend toward a reduction in the number of labeled cells in mutant mice but it does not reach significance (F). In the adult 
animal, (bottom row; E, E′) there is also a clear reduction in the number of Calr positive cells in the Arx+/− females (E′) versus control (E). F Displays 
the quantification of Calr positive cell numbers from adult animals. Counts are presented as a percent change from control in both the cortex and 
hippocampus. LV lateral ventricle, VZ ventricular zone, BG basal ganglia, Cx developing cortex, Hip hippocampus. L1 cortical layer 1, L2/3 cortical 
layers 2 and 3, L6 cortical layer 6
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loss of function (Arx−/y). At the time, a working antibody 
directed against Arx was not available, and we based our 
findings on the presence of a recombined band on geno-
typing at early postnatal ages. Many of the animals with 
the recombined bands died shortly after birth and only 3 
pups of 15 litters survived to adulthood [2]. The surviv-
ing Arx−/y males are now presumed to have had signifi-
cant persistence of Arx expression. In this study, we have 
shown variability of Arx expression (see below for dis-
cussion on Cre recombinase variability) that likely corre-
lates with survival; animals with greater levels of Arx live 
longer.
Though humans do not have variable levels of expres-
sion due to cre recombinase activity, there is likely vari-
ability of protein function based on mutation type and 
genetic background. This is consistent with the genotype 
Fig. 6 Neuropeptide Y immunohistochemistry at 2 postnatal time points revels alteration of expression at P14, but not adult. The top row (P14 
cortex, A–A″) demonstrates a reduction of NPY positive cells in the cortex between the control and both Arx−/y;Dlx5/6CIG and Arx+/−female animals. 
The second row, (P14 hippocampus, B–B″) illustrates a similar difference in NPY cells in the hippocampus as was found in the cortex. In the adult, 
there were no significant difference found between Arx+/−female and wildtype in either the cortex (third row; C–C′) or hippocampus (last row, 
D–D′). E, F Displays the quantification of NPY positive cell numbers from P14 (E) and adult (F) measuring the percent change from control in both 
the cortex and hippocampus. LV lateral ventricle, WM white matter, Cx developing cortex, Hip Hippocampus. L1 cortical layer 1, L2/3 cortical layers 2 
and 3, L6 cortical layer 6, DG dentate gyrus, CA1–CA3 Cornus Ammonis regions 3 and 1
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phenotype correlation found in humans with ARX muta-
tions. Indeed, truncation mutations that result in loss of 
protein, or mutations in the homeodomain that abol-
ish binding result in more severe XLAG phenotype, and 
these patients die early. On the other hand, missense 
mutations or expansion of the first or second polyala-
nine tracts in ARX, only cause early onset seizures and 
developmental delays, with the children surviving at 
least through childhood (for review of clinical features 
of ARX see [4, 6]). Previous reports on Arx have shown 
that these mutations do not cause Arx to lose repressor 
function in in vitro studies [30]. These less “severe” muta-
tions could act by altering Arx activity in a subset of cells. 
In fact, we have found that Arx with an expansion of the 
Fig. 7 Parvalbumin immunohistochemistry at 2 postnatal time points revels altered expression patterns in hippocampus and cortex. Top row 
(P14 cortex, A–A″) demonstrates an increase in Parv positive cells in the cortex of Arx−/y;Dlx5/6CIG with no change in the Arx+/−female animals. The 
hippocampus at P14 (second row, B–B″) reveals a consistent decrease in Parv expression in the Arx−/y;Dlx5/6CIG male but not Arx+/−female. Asterisks 
denote significant differences. In the adult, there was a consistent trend toward a decrease between Arx+/−female and wildtype male in both the 
cortex (third row; C–C′) and hippocampus (last row, D–D′). E, F Display the quantification of Parv positive cell numbers from P14 (E) and adult (F) 
measuring the percent change from control in both the cortex and ippocampus. LV lateral ventricle, WM white matter, Cx developing cortex, Hip 
hippocampus. L1 cortical layer 1, L2/3 cortical layers 2 and 3, L6 cortical layer 6, DG dentate gyrus, CA1–CA3 Cornus Ammonis regions 3 and 1
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first polyalanine tract leads to loss of repression of only a 
subset of targets [3]. Though mutation type can lead to a 
spectrum of conditions in humans and differing survival 
lengths in mice, these current studies confirm the impor-
tance of Arx for interneuron development and ultimate 
survival in the mice.
In these conditional mice with a more complete loss 
of Arx in the interneuron precursor population, we have 
found a loss of interneurons in the cortex and hippocam-
pus at e18.5 and P14, and no survival of males with com-
plete loss of Arx. This differs from findings in the two 
recently published mouse models of the expansion of the 
first polyalanine in Arx [10, 11]. Both expansion models 
had reductions in the numbers of striatal interneurons 
(both somatostatin- and Npy-expressing interneurons) 
with differing findings for cortical interneurons. Here at 
P14, we find a reduction of all interneurons in the hip-
pocampus as well as the cortex (there was a paradoxical 
increase in PV cells in layer 1 that we believe is due to 
staining differences). We previously reported that the 
CKO males had loss of Calb and Calr, but we know that 
these were hypomorphs with substantial Arx expres-
sion (data not shown). Hence, in people with truncation 
mutations or homeodomain loss of function changes 
and a more severe phenotype, they likely have severe loss 
of interneurons, whereas there is likely only a minimal 
change in interneuron numbers in the mice (or people) 
with polyalanine tract expansions. This suggests that the 
seizures and intellectual issues in people and mice with 
an expansion mutation is not due to decreased num-
bers of interneurons, but rather a change in function, 
anatomy, or connectivity which may be related to the 
postnatal function of Arx in interneurons, a role that is 
unknown at this time.
Increased calbindin in subpallium and regulation of striatal 
interneuron migration
The increased number of calbindin-expressing neurons 
in the striatum of Arx−/Y; Dlx5/6CIG mice suggests that 
Arx regulates one or more migratory guidance factors. 
The striatum consists of patch and matrix compart-
ments. The patch compartment, also known as stri-
osomes, contains Darpp32+ medium spiny neurons, 
while calbindin normally labels projection neurons 
receiving input from cortical areas in the matrix com-
partment of the striatum [31, 32]. In agreement with our 
immunohistochemical results on the Arx−/Y; Dlx5/6CIG 
mice, a microarray study of subpallial brain tissue from 
the conditional deletion of Arx from the forebrain of 
the developing mouse showed that calbindin is upregu-
lated at e14.5 in the absence of Arx [1, 33]. Normally, the 
neuropilin receptors are involved in repelling interneu-
rons from the subpallium toward the pallium [34]. For 
example, expression of a dominant negative Neuropi-
lin-1 allows interneurons to aberrantly enter the stria-
tum [35]. However, the effects of the neuropilins are not 
clear, as down-regulation of Neuropilin-2 seems to yield 
contrasting results. In one case, it has been found that 
Nkx2.1 directly represses Neuropilin-2 in post-mitotic 
interneurons, by allowing them to migrate into the stria-
tum, which normally repels cortical-bound interneu-
rons through Neuropilin-2 receptor interactions with 
Semaphorin-3F [36]. On the other hand, Dlx1/2 have 
also been found to repress Neuropilin-2 in interneurons 
that migrate dorsally into the cortex, which may allow 
them to pass through the Semaphorin-expressing stri-
atal area, as areas of Neuropilin-2-expressing ectopia are 
found in the SVZ of the LGE and MGE of Dlx1/2 mutant 
embryos [37]. Although Neuropilin-1 was found to be 
up-regulated in a microarray study on the Arx mutant 
[1], this is not likely sufficient to explain the increase 
of calbindin-expressing interneurons in the striatum of 
Arx−/Y; Dlx5/6CIG mice, because the cells were found 
evenly dispersed throughout the striatum, rather than 
clustered in ectopia. The complexity of ventral repellant 
and attractant forces upon interneurons is demonstrated 
by the Ctip2−/− mouse, which has clusters of ectopic 
cells expressing elevated levels of Neuropilin-1 despite 
no loss of striatal semaphorin expression [38]. There-
fore, some other signals are capable of overriding the 
repellant activity of the semaphorins. One known com-
ponent of this complexity is the Slit/Robo interaction, 
which is another pathway that has been hypothesized 
to be involved in repelling cortical-bound interneurons 
toward their dorsal route [39, 40]. Increased numbers of 
calbindin-positive cells are seen in both the cortex and 
striatum of Robo−/− mice [40].
The effect of heterozygous Arx expression
The EEGs of the adult Arx−/X; Dlx5/6CIG female mice 
showed great variation: mice either had normal back-
ground recordings or interruptions of chaotic activ-
ity, and 53 % of the females had seizures [2]. In females 
with a normal copy of Arx, there is an incomplete loss 
of Arx in Dlx5/6-expressing populations of interneu-
rons. This incomplete loss results in the survival of all the 
female animals and with varying degrees of neurologi-
cal manifestations. This incomplete loss of Arx, still was 
detrimental enough to result in a change in the profile 
of interneurons in the adult females, including a reduc-
tion of the calbindin and calretinin expressing subpopu-
lations but only trends in the Parv and Npy populations. 
This heterozygous loss contrasts to the complete loss 
in males where only the extremely rare male with poor 
recombination survived. The variability in the heterozy-
gous female animals and in X-linked recessive disorders 
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in people is often attributed to skewing of X-inactivation 
from the predicted 50  % suppression of each chromo-
some to the situation of either unexpectedly severe or 
mild phenotype in an X-linked disease. Here we clearly 
demonstrate the variability of X-inactivation.
Previously, we studied the role of X-inactivation in the 
phenotype of the Arx−/X; Dlx5/6CIG mice, and could not 
rule out a subtle contribution of X-inactivation to the 
variability of the phenotype seen in females with ARX 
mutations [2]. In the Arx−/X; Dlx5/6CIG mice that had 
efficient Cre-mediated recombination, a striated pattern 
of Arx expression resulted. Although, in general, large 
areas of the subpallium continued to express Arx, the 
amount of Arx expression, presumably due to X-inactiva-
tion, varied from animal to animal. Also of note is how 
early the Dlx5/6 enhancer could be activated. Frequently, 
striations of Arx-negative tissue extended from the ven-
tricular zone, through the subventricular zone, out into 
the mantle zone, suggesting that X inactivation occurs in 
the ventricular zone. While this has been demonstrated 
in the dorsal VZ and in cerebellum, it has not previously 
been shown in the ventral VZ [27, 41].
Heterogeneity in Dlx5/6 enhancer‑driven recombination
We observed an unexpectedly widespread expression 
of Arx in Dlx5/6-expressing populations of neurons 
in Arx−/Y; Dlx5/6CIG mice. The Dlx5/6CIG mouse has 
been widely used [42–44], but the animal-to-animal 
variation in its Cre-mediated recombination has not 
been investigated. In previous studies, deletion by loxP 
recombination has been measured by Western blot 
or PCR, in which each reaction represents at least an 
individual animal, if not multiple animals. One study 
of Cre-mediated genomic recombination found that 
the Cre driver line recombined the responder loxP 
sites in 46, 72, 76 and 93  % of animals, for 4 different 
responder lines, respectively [45]. Recombination was 
determined by PCR, which does not indicate the effi-
ciency of recombination within the animal, on a cell-
by-cell basis. However, the authors hypothesize that 
the efficiency they calculated was dependent, at least in 
part, on the accessibility of the chromatin structure at 
the integration site [45]. The issue of variably Cre medi-
ate recombination, has indeed been used to achieve 
low recombination efficiency to permit study of the 
morphology of scattered cells. One group found that 
efficiency of recombination within one animal could 
vary by approximately one thousand-fold depending 
on chromosomal location, target gene sequence and 
developmental age. The latter differences believed to 
be due to epigenetic changes in gene structure [46]. 
Overall, the variability of expression in males as well as 
X-inactivation in females results in a more challenging 
interpretation of the loss of the genes effect in both the 
normal and disease states.
Role of Arx in interneuron development
This phenotypic description of the changes in interneu-
ron development highlights the importance of Arx in cor-
tical interneuron development. This work suggests that 
the main function for Arx is the transcriptional control of 
cues or the machinery to enable migration from the ven-
tral forebrain into the cortex. Our previous study, which 
profiled the changes in expression in the ventral forebrain 
after Arx loss demonstrated that genes involved in migra-
tion and axonal guidance were most dysregulated [1]. 
This was confirmed with work that demonstrated that 
Arx was downstream of the Dlx1/2 transcription factors 
and involved in migration [22]. While this work does 
not further the molecular underpinnings of this shift in 
migration, it demonstrates that there is a ventral shift in 
migration of interneuron precursors and that there is not 
a loss or shift in fate of these cells.
Conclusion
In summary, we have found that loss of Arx in ven-
tral progenitors leads to perinatal lethality in mice and 
appears to shift the progenitors ventrally and decrease 
the dorsal migration of these precursors. The end result 
is a reduction of interneurons in the cortex in the Arx−/X; 
Dlx5/6CIG mouse mice in perinatal and early postnatal 
time periods. In addition, we show that X-inactivation 
results in striated patterns of expression in the heterozy-
gous females providing strong evidence that variability in 
X-inactivation can explain the variable phenotype found 
in human females with ARX mutations. These finding 
continue to shed light on the role of Arx in ventral neural 
progenitor function and the spectrum of Arx related neu-
rological disorders.
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